Comparison Chart Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE 16:00:00 2026-10-16 EDT			5-day change	1st Jan Change
2.170 ^USD	-7.26%		-18.42%	-21.09%

10-08	Perspective Therapeutics, Inc. Receives Fast Track Designation for PSV359 for Treatment of Adult Patients with Locally Advanced Unresectable And/Or Metastatic FAP-Positive Solitary Fibrous Tumors	CI
10-08	Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PERSPECTIVE THERAPEUTICS, INC.	Other Biotechnology & Medical Research	-7.26%	-18.42%	-21.09%	-51.67%	-64.77%	248M